Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,722 | 45,277 | 61,653 | 68,264 | 36,342 |
| Marketable Securities | 126,081 | 172,294 | 186,409 | 180,339 | 143,280 |
| Receivables | 686 | 484 | 597 | 637 | 633 |
| TOTAL | $184,361 | $231,550 | $256,573 | $259,354 | $190,881 |
| Non-Current Assets | |||||
| PPE Net | 1,513 | 1,099 | 1,145 | 1,276 | 1,277 |
| Investments And Advances | 33,602 | 12,242 | 0 | 7,221 | 23,955 |
| Intangibles | 6,954 | 6,973 | 6,992 | 7,011 | 7,030 |
| Other Non-Current Assets | 3,275 | 2,732 | 2,922 | 3,114 | 3,384 |
| TOTAL | $45,344 | $23,046 | $11,059 | $18,622 | $35,646 |
| Total Assets | $229,705 | $254,596 | $267,632 | $277,976 | $226,527 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,190 | 10,351 | 7,667 | 5,703 | 8,121 |
| Accrued Expenses | 7,263 | 8,701 | 9,154 | 7,571 | 5,687 |
| TOTAL | $18,258 | $21,938 | $19,789 | $16,217 | $16,726 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 34,270 | 34,670 | 27,638 | 25,640 | 29,235 |
| TOTAL | $34,637 | $35,037 | $28,005 | $26,007 | $29,602 |
| Total Liabilities | $52,895 | $56,975 | $47,794 | $42,224 | $46,328 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,679 | 66,693 | 66,683 | 66,672 | 66,582 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -710,475 | -682,315 | -654,680 | -634,728 | -614,196 |
| Other shareholders' equity | -354 | -897 | -1,465 | -1,326 | -972 |
| TOTAL | $176,810 | $197,621 | $219,838 | $235,752 | $180,199 |
| Total Liabilities And Equity | $229,705 | $254,596 | $267,632 | $277,976 | $226,527 |